Articles with public access mandates - TOSHIYASU TANIGUCHILearn more
Not available anywhere: 2
Resistance to PARP inhibitors mediated by secondary BRCA1/2 mutations
KK Dhillon, T Taniguchi
PARP Inhibitors for Cancer Therapy, 431-452, 2015
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
FANC-BLM-Opathies: Recent Progress in the Understanding of Molecular Pathogenesis of Fanconi Anemia and Its Connection with Bloom Syndrome
T Taniguchi, KK Dhillon, M Castella, RS Cheung, C Jacquemont
New-Opathies: An Emerging Molecular Reclassification of Human Disease, 189-230, 2012
Mandates: US National Institutes of Health
Available somewhere: 23
Secondary Somatic Mutations Restoring BRCA1/2 Predict Chemotherapy Resistance in Hereditary Ovarian Carcinomas
B Norquist, KA Wurz, CC Pennil, R Garcia, J Gross, W Sakai, BY Karlan, ...
Journal of clinical oncology 29 (22), 3008-3015, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Gene Expression Profile of BRCAness That Correlates With Responsiveness to Chemotherapy and With Outcome in Patients With Epithelial Ovarian Cancer
PA Konstantinopoulos, D Spentzos, BY Karlan, T Taniguchi, E Fountzilas, ...
Journal of clinical oncology 28 (22), 3555-3561, 2010
Mandates: US National Institutes of Health
Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance
EM Swisher, W Sakai, BY Karlan, K Wurz, N Urban, T Taniguchi
Cancer research 68 (8), 2581-2586, 2008
Mandates: US National Institutes of Health
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma
W Sakai, EM Swisher, C Jacquemont, KV Chandramohan, FJ Couch, ...
Cancer research 69 (16), 6381-6386, 2009
Mandates: US National Institutes of Health
Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L
DH Chen, JE Below, A Shimamura, SB Keel, M Matsushita, J Wolff, Y Sul, ...
The American Journal of Human Genetics 98 (6), 1146-1158, 2016
Mandates: US National Institutes of Health, US Department of Veterans Affairs
MicroRNA-138 modulates DNA damage response by repressing histone H2AX expression
Y Wang, JW Huang, M Li, WK Cavenee, PS Mitchell, X Zhou, M Tewari, ...
Molecular Cancer Research 9 (8), 1100-1111, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Secondary mutations of BRCA1/2 and drug resistance
KK Dhillon, EM Swisher, T Taniguchi
Cancer science 102 (4), 663-669, 2011
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
MiR-96 downregulates REV1 and RAD51 to promote cellular sensitivity to cisplatin and PARP inhibition
Y Wang, JW Huang, P Calses, CJ Kemp, T Taniguchi
Cancer research 72 (16), 4037-4046, 2012
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1
R Drost, KK Dhillon, H Van Der Gulden, I Van Der Heijden, I Brandsma, ...
The Journal of clinical investigation 126 (8), 2903-2918, 2016
Mandates: US National Institutes of Health, Howard Hughes Medical Institute …
Methylation and protein expression of DNA repair genes: association with chemotherapy exposure and survival in sporadic ovarian and peritoneal carcinomas
EM Swisher, RM Gonzalez, T Taniguchi, RL Garcia, T Walsh, BA Goff, ...
Molecular cancer 8, 1-11, 2009
Mandates: US National Institutes of Health
MicroRNAs and DNA damage response: implications for cancer therapy
Y Wang, T Taniguchi
Cell cycle 12 (1), 32-42, 2013
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Systematic screen identifies miRNAs that target RAD51 and RAD51D to enhance chemosensitivity
JW Huang, Y Wang, KK Dhillon, P Calses, E Villegas, PS Mitchell, ...
Molecular cancer research 11 (12), 1564-1573, 2013
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
FANCI regulates recruitment of the FA core complex at sites of DNA damage independently of FANCD2
M Castella, C Jacquemont, EL Thompson, JE Yeo, RS Cheung, ...
PLoS genetics 11 (10), e1005563, 2015
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Non-specific chemical inhibition of the Fanconi anemia pathway sensitizes cancer cells to cisplatin
C Jacquemont, JA Simon, AD D'Andrea, T Taniguchi
Molecular cancer 11, 1-15, 2012
Mandates: US National Institutes of Health
Recent insights into the molecular basis of Fanconi anemia: genes, modifiers, and drivers
RS Cheung, T Taniguchi
International journal of hematology 106, 335-344, 2017
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
p53 is positively regulated by miR-542-3p
Y Wang, JW Huang, M Castella, DG Huntsman, T Taniguchi
Cancer research 74 (12), 3218-3227, 2014
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
DGCR8 mediates repair of UV-induced DNA damage independently of RNA processing
PC Calses, KK Dhillon, N Tucker, Y Chi, J Huang, M Kawasumi, ...
Cell reports 19 (1), 162-174, 2017
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, Canadian …
Ubiquitination-linked phosphorylation of the FANCI S/TQ cluster contributes to activation of the Fanconi anemia I/D2 complex
RS Cheung, M Castella, A Abeyta, PR Gafken, N Tucker, T Taniguchi
Cell reports 19 (12), 2432-2440, 2017
Mandates: US National Science Foundation, US National Institutes of Health, Howard …
Publication and funding information is determined automatically by a computer program